Core Viewpoint - Medline Inc. has successfully closed a secondary offering of 86,250,000 shares of its Class A common stock at a public price of $41.00 per share, with the underwriters fully exercising their option to purchase an additional 11,250,000 shares [1] Group 1: Offering Details - The offering was conducted by selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC, and a subsidiary of the Abu Dhabi Investment Authority [1] - Medline did not sell any shares in the offering and did not receive any proceeds from the sale [2] - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan acted as global coordinators and joint bookrunning managers for the offering [3] Group 2: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [6] - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving clinical, financial, and operational outcomes for healthcare providers [6] - Medline is headquartered in Northfield, Illinois, employs over 45,000 people globally, and operates in more than 100 countries [6]
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters' option to purchase additional shares